208 related articles for article (PubMed ID: 6252831)
61. The in vitro activity of moxalactam against 430 clinical, bacterial isolates.
Digranes A; Benonisen E; Dibb WL; Ostervold B
Acta Pathol Microbiol Immunol Scand B; 1982 Feb; 90(1):69-72. PubMed ID: 6211028
[TBL] [Abstract][Full Text] [Related]
62. In vitro evaluation of LY127935 (6050S) compared with cefotaxime, eight other beta-lactams and two aminoglycosides.
Barry AL; Thornsberry C; Jones RN
J Antimicrob Chemother; 1980 Nov; 6(6):775-84. PubMed ID: 6254942
[No Abstract] [Full Text] [Related]
63. Comparison of the activity of cefoperazone, cefuroxime and cefoxitin against Gram-negative bacilli and synergy studies with cefoperazone and ticarcillin.
Miles HM; Carson M; Pavillard ER
Drugs; 1981; 22 Suppl 1():15-9. PubMed ID: 6456885
[TBL] [Abstract][Full Text] [Related]
64. In vitro combination effects of cefsulodin, moxalactam and cefoperazone with four aminoglycosides on nonfermenting nosocomial gram-negative bacteria.
Daschner FD; Steffens A; Mählmann M; Metzger M
Arzneimittelforschung; 1982; 32(5):531-3. PubMed ID: 6213241
[TBL] [Abstract][Full Text] [Related]
65. Bactericidal activity of cefoperazone in comparison with other beta-lactam antibiotics and gentamicin.
Welch DF; Matsen JM
Clin Ther; 1980; 3(Spec Issue):127-9. PubMed ID: 6446385
[TBL] [Abstract][Full Text] [Related]
66. Antibacterial activity of moxalactam (LY-127935) compared with cefotaxime and other beta-lactam antibiotics against clinical isolates of enterobacteriacea and non-fermenters.
Verbist L
Arzneimittelforschung; 1981; 31(6):982-6. PubMed ID: 6266430
[TBL] [Abstract][Full Text] [Related]
67. Pharmacokinetics and bacteriological efficacy of moxalactam (LY127935), netilmicin, and ampicillin in experimental gram-negative enteric bacillary meningitis.
Schaad UB; McCracken GH; Loock CA; Thomas ML
Antimicrob Agents Chemother; 1980 Mar; 17(3):406-11. PubMed ID: 6448576
[TBL] [Abstract][Full Text] [Related]
68. Quality control of moxalactam susceptibility disks.
Barry AL; Preston DA; Jones RN; Gavan TL; Thornsberry C
J Clin Microbiol; 1983 Jun; 17(6):1032-8. PubMed ID: 6223936
[TBL] [Abstract][Full Text] [Related]
69. Pharmacokinetics and bacteriologic efficacy of moxalactam, cefotaxime, cefoperazone, and rocephin in experimental bacterial meningitis.
Schaad UB; McCracken GH; Loock CA; Thomas ML
J Infect Dis; 1981 Feb; 143(2):156-63. PubMed ID: 6260870
[TBL] [Abstract][Full Text] [Related]
70. In vitro activity of moxalactam against pathogenic bacteria and its comparison with other antibiotics.
Perrymann F; Flournoy DJ; Qadri SM
Chemotherapy; 1983; 29(1):37-42. PubMed ID: 6219865
[TBL] [Abstract][Full Text] [Related]
71. Comparison of in vitro activities of eight beta-lactamase-stable cephalosporins against beta-lactamase-producing gram-negative bacilli.
Verbist L
Antimicrob Agents Chemother; 1981 Mar; 19(3):407-13. PubMed ID: 6972728
[TBL] [Abstract][Full Text] [Related]
72. In vitro comparison of N-formimidoyl thienamycin, piperacillin, cefotaxime, and cefoperazone.
Tutlane VA; McCloskey RV; Trent JA
Antimicrob Agents Chemother; 1981 Jul; 20(1):140-3. PubMed ID: 6269481
[TBL] [Abstract][Full Text] [Related]
73. Evaluation of the in vitro activity of BMY-28142, a new broad-spectrum cephalosporin.
Fuchs PC; Jones RN; Barry AL; Thornsberry C
Antimicrob Agents Chemother; 1985 May; 27(5):679-82. PubMed ID: 3893316
[TBL] [Abstract][Full Text] [Related]
74. Susceptibility of gentamicin sensitive and resistant gram negative bacilli to ceftazidime.
Bremner DA
Pathology; 1987 Jul; 19(3):274-6. PubMed ID: 3124067
[TBL] [Abstract][Full Text] [Related]
75. [In vitro antibacterial activity of eight third generation cephalosporins (author's transl)].
Deforges L; Le Van Thoi J; Soussy CJ; Duval J
Pathol Biol (Paris); 1982 Jun; 30(6):363-9. PubMed ID: 6810282
[TBL] [Abstract][Full Text] [Related]
76. Comparative activity of seven extended-spectrum cephalosporins against gram-negative bacilli from blood cultures.
Norris SM; Guenthner SH; Wenzel RP
J Antimicrob Chemother; 1985 Aug; 16(2):183-8. PubMed ID: 3934124
[TBL] [Abstract][Full Text] [Related]
77. Susceptibility of bacterial pathogens to cefotetan judged by MIC and disc tests.
Grimm H
J Antimicrob Chemother; 1983 Jan; 11 Suppl():37-43. PubMed ID: 6573324
[TBL] [Abstract][Full Text] [Related]
78. [Microbiological evaluation of the antibacterial activity of cefotaxime in comparison with other cephalosporins].
Concia E; Marone P; Verani D; Marino P
Boll Ist Sieroter Milan; 1982; 61(4):300-8. PubMed ID: 6100233
[TBL] [Abstract][Full Text] [Related]
79. Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.
Giamarellou H
Am J Med; 1986 Jun; 80(6B):126-37. PubMed ID: 3088998
[TBL] [Abstract][Full Text] [Related]
80. The in vitro activity of ceftazidime against resistant clinical isolates.
Van Landuyt HW; Denolf BL; Pyckavet M; Lambert AM
Infection; 1983; 11 Suppl 1():S23-7. PubMed ID: 6299967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
